M. L. Thomson

2.2k total citations
56 papers, 1.6k citations indexed

About

M. L. Thomson is a scholar working on Pulmonary and Respiratory Medicine, Physiology and Health, Toxicology and Mutagenesis. According to data from OpenAlex, M. L. Thomson has authored 56 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Pulmonary and Respiratory Medicine, 10 papers in Physiology and 6 papers in Health, Toxicology and Mutagenesis. Recurrent topics in M. L. Thomson's work include Inhalation and Respiratory Drug Delivery (15 papers), Chronic Obstructive Pulmonary Disease (COPD) Research (12 papers) and Respiratory and Cough-Related Research (5 papers). M. L. Thomson is often cited by papers focused on Inhalation and Respiratory Drug Delivery (15 papers), Chronic Obstructive Pulmonary Disease (COPD) Research (12 papers) and Respiratory and Cough-Related Research (5 papers). M. L. Thomson collaborates with scholars based in United Kingdom, Australia and Canada. M. L. Thomson's co-authors include D Pavia, Harry S. Shannon, Demetri Pavia, Michael D. Short, S W Clarke, SW Clarke, F. F. Cinkotai, C. E. Dent, A. Holzel and A. C. Chamberlain and has published in prestigious journals such as Nature, New England Journal of Medicine and The Lancet.

In The Last Decade

M. L. Thomson

56 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
M. L. Thomson United Kingdom 25 991 455 181 104 85 56 1.6k
M. Henry Williams United States 26 1.5k 1.5× 821 1.8× 84 0.5× 31 0.3× 60 0.7× 83 2.2k
Walter T. Kaltenborn United States 18 803 0.8× 809 1.8× 90 0.5× 176 1.7× 38 0.4× 23 1.6k
Attilio D. Renzetti United States 25 1.7k 1.7× 671 1.5× 137 0.8× 28 0.3× 63 0.7× 77 2.4k
D J Lane United Kingdom 20 1.1k 1.2× 392 0.9× 110 0.6× 42 0.4× 59 0.7× 56 1.8k
C. M. Salome Australia 21 1.5k 1.5× 1.7k 3.8× 73 0.4× 72 0.7× 56 0.7× 25 2.1k
Archie F. Wilson United States 30 1.3k 1.4× 692 1.5× 104 0.6× 42 0.4× 147 1.7× 118 2.5k
W. G. Reddan United States 25 800 0.8× 642 1.4× 205 1.1× 16 0.2× 74 0.9× 46 2.0k
Herbert I. Goldman United States 17 837 0.8× 371 0.8× 108 0.6× 14 0.1× 46 0.5× 38 1.7k
J. B. L. Howell United Kingdom 24 1.2k 1.2× 684 1.5× 48 0.3× 20 0.2× 49 0.6× 61 2.0k
Giuseppe Maria Corbo Italy 21 881 0.9× 883 1.9× 287 1.6× 55 0.5× 40 0.5× 64 1.7k

Countries citing papers authored by M. L. Thomson

Since Specialization
Citations

This map shows the geographic impact of M. L. Thomson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. L. Thomson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. L. Thomson more than expected).

Fields of papers citing papers by M. L. Thomson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M. L. Thomson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. L. Thomson. The network helps show where M. L. Thomson may publish in the future.

Co-authorship network of co-authors of M. L. Thomson

This figure shows the co-authorship network connecting the top 25 collaborators of M. L. Thomson. A scholar is included among the top collaborators of M. L. Thomson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M. L. Thomson. M. L. Thomson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Thomson, M. L., et al.. (1995). Prescribing benzodiazepines for noninstitutionalized elderly.. PubMed. 41. 792–8. 23 indexed citations
2.
Thomson, M. L.. (1991). Heavy birthweight in Native Indians of British Columbia.. PubMed. 81(6). 443–6. 27 indexed citations
3.
Pavia, D, M. L. Thomson, & SW Clarke. (1978). Enhanced clearance of secretions from the human lung after the administration of hypertonic saline aerosol.. PubMed. 117(2). 199–203. 84 indexed citations
4.
Pavia, Demetri, M. L. Thomson, & Harry S. Shannon. (1977). Aerosol Inhalation and Depth of Deposition in the Human Lung. Archives of Environmental Health An International Journal. 32(3). 131–137. 28 indexed citations
5.
Thomson, M. L., et al.. (1977). Ipratropium bromide: mucociliary clearance rate and airway resistance in normal subjects. British Journal of Diseases of the Chest. 71(3). 173–178. 27 indexed citations
6.
Thomson, M. L. & Demetri Pavia. (1974). Particle Penetration and Clearance in the Human Lung. Archives of Environmental Health An International Journal. 29(4). 214–219. 36 indexed citations
7.
Thomson, M. L., D Pavia, Ian Gregg, & J E Stark. (1974). Bromhexine and mucociliary clearance in chronic bronchitis. British Journal of Diseases of the Chest. 68(1). 21–27. 22 indexed citations
8.
Thomson, M. L. & Demetri Pavia. (1973). Long-Term Tobacco Smoking and Mucociliary Clearance. Archives of Environmental Health An International Journal. 26(2). 86–89. 29 indexed citations
9.
Pavia, D & M. L. Thomson. (1971). INHIBITION OF MUCOCILIARY CLEARANCE FROM THE HUMAN LUNG BY HYOSCINE. The Lancet. 297(7696). 449–450. 24 indexed citations
10.
Pavia, D, Michael D. Short, & M. L. Thomson. (1970). No Demonstrable Long Term Effects of Cigarette Smoking on the Mucociliary Mechanism of the Human Lung. Nature. 226(5252). 1228–1231. 23 indexed citations
11.
Chamberlain, A. C., et al.. (1967). Elimination of 5µ Particles from the Human Lung. Nature. 215(5096). 30–33. 58 indexed citations
12.
Thomson, M. L., et al.. (1965). THE DISCRIMINANT VALUE OF PULMONARY FUNCTION TESTS IN ASBESTOSIS. Annals of the New York Academy of Sciences. 132(1). 421–436. 16 indexed citations
13.
Thomson, M. L., et al.. (1964). Expiratory Peak Flow. BMJ. 2(5401). 123.1–123. 10 indexed citations
14.
Thomson, M. L., et al.. (1964). THE MERITS OF OXYGEN, AIR, AND HELIUM AS SINGLE-BREATH INDICATORS OF NONUNIFORM DISTRIBUTION OF INSPIRED GAS.. PubMed. 89. 859–69. 3 indexed citations
15.
Thomson, M. L., et al.. (1961). Pulmonary diffusion at small lung volumes in asbestosis and chronic bronchitis with emphysema.. PubMed. 21. 15–9. 2 indexed citations
16.
Phair, John J., et al.. (1958). Some factors in the design, organization and implementation of an air hygiene survey.. PubMed. 1(1-2). 18–30. 1 indexed citations
17.
18.
Thomson, M. L.. (1954). A comparison between the number and distribution of functioning eccrine sweat glands in Europeans and Africans*. The Journal of Physiology. 123(2). 225–233. 63 indexed citations
19.
Thomson, M. L., et al.. (1953). AMINO-ACIDURIA IN LEAD POISONING A CASE IN CHILDHOOD. The Lancet. 262(6776). 66–68. 65 indexed citations
20.
Thomson, M. L., et al.. (1952). Mercury Nephrosis in Young Children. BMJ. 1(4754). 358–360. 40 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026